Target intelligence / Profile preview

Afamin (AFM)

Target
AFM
Molecular classification
Other (serum transport protein; member of albumin family)
01

Overview

Afamin (AFM) is a secreted, monomeric glycoprotein that belongs to the albumin family of serum transport proteins, which also includes serum albumin, alpha-fetoprotein, and vitamin D binding protein[1][3]. It is primarily synthesized in the liver and circulates in blood at low microgram-per-milliliter concentrations[1][3]. Afamin’s biological functions include binding and transport of vitamin E (alpha-tocopherol) and acting as a carrier for Wnt proteins, thereby facilitating their solubility and availability for signaling, especially at the blood-brain barrier and in bone biology[1][2]. Recent studies have suggested that afamin may play a role as a chemoattractant for preosteoblasts, coupling bone resorption and formation, and as a unique carrier for several lipidated Wnt ligands distinct from other albumin family proteins[1][2]. Abnormal levels of afamin have been associated with several conditions, including pre-eclampsia, ovarian cancer, and both gestational and type 2 diabetes, suggesting its potential utility as a biomarker in these diseases[1][3]. There are currently no drugs known to act directly on afamin, and it is not considered a therapeutic target such as a receptor, enzyme, or transporter[1][3][4].

Other names
Alpha-albuminvitamin E binding proteinALB2ALBAAlpha-AlbALFalpha-Alb
02

Biological functions

Transport of vitamin E (tocopherol) and other hydrophobic moleculesCarrier for Wnt proteins and solubilization of lipid-modified proteinsPotential chemoattractant for preosteoblasts
03

Disease associations

Cancer (notably ovarian cancer)Pre-eclampsiaDiabetes (including gestational and type 2)Other (possible biomarker roles in diverse conditions)
04

Biomarkers

Possible diagnostic and prognostic biomarker for pre-eclampsiaPotential biomarker for ovarian cancerPotential biomarker for diabetes (type 2 and gestational)

Beyond the preview

Go deeper on Afamin (AFM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Afamin (AFM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call